Translational Genomics and Epigenomics Laboratory

BEACON Biomarkers Laboratory

Site

BEACON Biomarkers Laboratory-Austin

BEACON Biomarkers Laboratory

Accreditation No.

19912

Site No.

23962

Date of Accreditation

21 Dec 2017

Address

Level 8, Lance Townsend Building, Austin Hospital, 145 Studley Road
Heidelberg, VIC 3084
Australia

mdhs.unimelb.edu.au/centre-for-cancer-research

Contact

Prof Vijayaragavan Muralidharan P: +61 (03) 94963670

Availability

Services available to external clients

Supervision

Not Applicable

Translational Genomics and Epigenomics Laboratory address map

Scope of Accreditation

Print scopes

Withdrawn 12 Jan 2026

Voluntary

BEACON Biomarkers Laboratory-Austin

ISO 15189 (2012)

  • This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.

Human Pathology

Withdrawn
Service Product Determinant
Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Whole exome sequencing studies for inherited (germline) DNA/RNA changes
Molecular genetics - DNA sequencing Blood; Extracted DNA; Formalin-fixed paraffin-embedded (FFPE) tissues; Tissues DNA sequence analysis
Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted panels for non-inherited (somatic) DNA/RNA changes Blood; Fluids; Formalin-fixed paraffin-embedded (FFPE) tissues; Plasma; Tissues Blood borne tumours; Essential thrombocythemia (ET); Glioblastoma; Inherited cancer syndromes; MGMT promoter methylation analysis; MLH1 promoter methylation analysis; Nucleic acid analysis for specific variants; Polycythaemia vera; Primary myelofibrosis; Solid tumours
Molecular genetics - Investigation of constitutional genetic variants - Carrier testing - Targeted genes Blood; Formalin-fixed paraffin-embedded (FFPE) tissues Blood borne tumours; Inherited blood borne tumours; Inherited cancer syndromes; Nucleic acid analysis for specific variants; Nucleic acid analysis for unknown variants; Polycythaemia; Solid tumours
Molecular genetics - Predictive genetic testing - Targeted genes Blood; Formalin-fixed paraffin-embedded (FFPE) tissues Blood borne tumours; Breast cancer; Inherited blood borne tumours; Inherited cancer syndromes; Inherited colorectal cancer; Inherited disorders; Inherited solid tumours; Solid tumours
Molecular genetics - Predictive genetic testing - Targeted panels for inherited (germline) DNA/RNA changes Blood; Extracted DNA; Tissues Blood borne tumours; Breast cancer; Hereditary colorectal cancer; Inherited blood borne tumours; Inherited cancer syndromes; Inherited colorectal cancer; Inherited solid tumours; Solid tumours
Molecular genetics - RNA extraction Blood; Buffy coat; Formalin-fixed paraffin-embedded (FFPE) tissues; Tissues Viable RNA; Viable RNA for sequencing
Molecular genetics - Screening for an unknown mutation - Targeted genes Blood; Extracted DNA; Formalin-fixed paraffin-embedded (FFPE) tissues; Plasma; Tissues Blood borne tumours; Breast cancer; Inherited blood borne tumours; Inherited cancer syndromes; Inherited solid tumours; Solid tumours
Molecular genetics - Screening for an unknown mutation - Targeted panels for non-inherited (somatic) DNA/RNA changes Blood; Formalin-fixed paraffin-embedded (FFPE) tissues; Fresh tissue Blood borne tumours; Inherited cancer syndromes; Nucleic acid analysis for unknown variants; Solid tumours
Molecular genetics and/or cytogenetics - Bioinformatic analysis DNA sequences; RNA sequences Primary analysis - Conversion of instrument file to FASTQ or FASTA file; Tertiary analysis - Data annotation and interpretation

ISO 15189 (2022)

  • This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.

Human Pathology

Withdrawn
Service Product Determinant
Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes Blood; Formalin-fixed paraffin-embedded (FFPE) tissues Blood borne tumours; Breast cancer; Solid tumours
Molecular genetics - DNA extraction Blood; Formalin-fixed paraffin-embedded (FFPE) tissues Viable DNA; Viable DNA for sequencing
Molecular genetics - Detection and characterisation of cell free RNA (cfRNA) and/or cell free DNA (cfDNA) and/or cell free TNA (cfTNA) and/or circulating tumour DNA (ctDNA) in cancer screening and/or cancer genetic testing Blood Nucleic acid analysis for specific variants
Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted genes Blood; Formalin-fixed paraffin-embedded (FFPE) tissues BRCA1 methylation; Blood borne tumours; Inherited cancer syndromes; Nucleic acid analysis for specific variants; Solid tumours

The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.